MedTrace Logo

A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.

NCT04812860 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 187

Last updated 2025-06-22

No results posted yet for this study

Summary

The purpose of this study was to evaluate the Efficacy and safety of HR18042 tablets for the Treatment of Post-surgical Pain After extraction of impacted tooth, find the optimal dose.

Conditions

  • Moderate to Severe Acute Pain

Interventions

DRUG

HR18042

Tablet, Dosing frequency: once daily, Route of administration: oral

DRUG

HR18042

Tablet,Dosing frequency: once daily, Route of administration: oral

DRUG

HR18042

Tablet,Dosing frequency: once daily, Route of administration: oral

DRUG

Tramadol hydrochloride ER

Tablet,Dosing frequency: once daily, Route of administration: oral

DRUG

Placebo

Tablet,Dosing frequency: once daily, Route of administration: oral

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-08
Primary Completion
2021-01-25
Completion
2021-01-25

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04812860 on ClinicalTrials.gov